Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires
暂无分享,去创建一个
[1] H. Rammensee,et al. Definition of peptide binding motifs amongst the HLA-A*30 allelic group. , 2000, Tissue antigens.
[2] John Sidney,et al. Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif , 2001, Journal of Virology.
[3] John Sidney,et al. Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes , 1997, Immunogenetics.
[4] A Sette,et al. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. , 1999, Journal of immunology.
[5] John Sidney,et al. Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins1 , 2000, The Journal of Immunology.
[6] J. Sidney,et al. The HLA-A0207 Peptide Binding Repertoire is Limited to a Subset of the A0201 Repertoire , 1997 .
[7] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[8] D. Flower,et al. Identifiying Human MHC Supertypes Using Bioinformatic Methods , 2004, The Journal of Immunology.
[9] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[10] R W Chesnut,et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. , 1997, The Journal of clinical investigation.
[11] J. Trapani,et al. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody , 2006, Immunogenetics.
[12] A. Sette,et al. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. , 1998, Human immunology.
[13] J. Sidney,et al. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules. , 1999, Human immunology.
[14] H. Rammensee,et al. HLA-A26 subtype A pockets accommodate acidic N-termini of ligands , 1998, Immunogenetics.
[15] N. Suciu-Foca,et al. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs. , 1993, Journal of immunology.
[16] M F del Guercio,et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.
[17] Steven G.E. Marsh,et al. Nomenclature for factors of the HLA system , 1975 .
[18] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.
[19] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[20] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[21] M F del Guercio,et al. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. , 1995, Journal of immunology.
[22] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[23] B. Drénou,et al. QUANTIFICATION AND MOLECULAR ANALYSIS OF PLASMATIC HLA‐BCw MOLECULES WITH A LOCUS B AND Cw HLA SPECIFIC mAb (B1.23.2mAb) , 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[24] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[25] J. Trapani,et al. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30. , 1989, Journal of immunology.
[26] B. Malissen,et al. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. , 2008, Tissue antigens.
[27] O. Lund,et al. Definition of supertypes for HLA molecules using clustering of specificity matrices , 2004, Immunogenetics.
[28] F. Marincola,et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. , 1996, Journal of immunology.
[29] H. Zinszner,et al. Nucleotide sequence of the HLA-A26 class I gene: identification of specific residues and molecular mapping of public HLA class I epitopes. , 1990, Human immunology.
[30] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[31] M F del Guercio,et al. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. , 1996, Journal of immunology.
[32] S. Burrows,et al. Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune recognition of EBV‐infected cells by LMP1‐specific cytotoxic T lymphocytes , 1998, European journal of immunology.
[33] V. Gnau,et al. Peptide motifs of HLA-B58, B60, B61, and B62 molecules , 2004, Immunogenetics.
[34] Rajiv Khanna,et al. Promiscuous CTL Recognition of Viral Epitopes on Multiple Human Leukocyte Antigens: Biological Validation of the Proposed HLA A24 Supertype 1 , 2003, The Journal of Immunology.
[35] A. Sette,et al. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. , 1998, Journal of immunology.
[36] B. Walker,et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. , 1997, Journal of immunology.
[37] John Sidney,et al. Measurement of MHC/Peptide Interactions by Gel Filtration , 1999, Current protocols in immunology.
[38] A Sette,et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. , 1994, Journal of immunology.
[39] Todd M. Allen,et al. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. , 1998, Journal of immunology.
[40] J. Kalil,et al. Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells. , 1983, Journal of immunology.
[41] John Sidney,et al. Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution , 2003, Immunogenetics.
[42] C. Bordignon,et al. Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+ cytotoxic T cell line. , 1996, Journal of immunology.
[43] P. Romero,et al. HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44 (*) , 1996, The Journal of Biological Chemistry.
[44] A Sette,et al. Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. , 2001, Human immunology.
[45] A. Kijlstra,et al. HLA typing in birdshot chorioretinopathy. , 1988, American journal of ophthalmology.
[46] W. Green,et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. , 1982, American journal of ophthalmology.
[47] E. Coligan. Current protocols in immunology , 1991 .
[48] J. Sidney,et al. Characterization of the Peptide-Binding Specificity of Mamu-B*17 and Identification of Mamu-B*17-Restricted Epitopes Derived from Simian Immunodeficiency Virus Proteins1 , 2002, The Journal of Immunology.
[49] A. Toubert,et al. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] W R Mayr,et al. Nomenclature for factors of the HLA system, 2002. , 2002, Tissue antigens.
[51] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[52] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[53] John Sidney,et al. Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype 1 , 2003, The Journal of Immunology.
[54] J. Sidney,et al. The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire. , 1997, Human immunology.
[55] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.